Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced OneSpaWorld (NASDAQ:OSW) as the newest Niagen Plus™ provider, engaged to offer pharmaceutical grade Niagen IV at over 80 Medi-Spa clinics onboard high-end cruise ships. Marking Niagen Bioscience's first cruise ship clinic partnership, this collaboration brings Niagen IV to guests at sea.

This partnership extends Niagen Bioscience's fast-growing clinical channel for Niagen Plus, with Niagen IV and injections available at over 1,200 top healthcare, wellness, and longevity clinics across the U.S. Niagen Bioscience continues to scale Niagen IV through premium medical and wellness providers, and OneSpaWorld introduces an entirely new point of access: high-intent, on-vacation consumers seeking elevated wellness experiences while traveling.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.